Sponsor
Sponsor
Plorvo
Find Out More
SGLT2 Inhibitors and Other Glucose-Lowering Agents with Weight Benefit – 1 CME Point
Speaker
Mr. Yousaf Ahmad
Pharmaceutical Expert
Yousaf Ahmad is a highly versatile senior executive healthcare professional known for his board-level leadership and transformational impact across large, complex healthcare organizations. With a proven track record in both NHS and corporate settings, he brings together expertise in clinical care, governance, and international pharmacy to design and deliver innovative strategies that improve efficiency, productivity, and patient outcomes. Yousaf’s strengths, as recognized by Strengthscope, include collaboration, compassion, creativity, developing others, empathy, self-improvement, and strategic-mindedness. Currently, Yousaf serves in multiple high-profile roles, including Non-executive Director, Expert Advisory Board Member, Digital Healthcare Expert, Global Pharmacy Ambassador, School Governor, and University Educator. He is especially valued for his deep knowledge in pharmaceutical practice, digital health, educational models, and for his insight into board and corporate governance at the highest level.
If you register now, then you can choose to watch it live or later. The webinar will be available later, but without any CME points.
>LIVE: 1 August 2026, Saturday 10:00 am (UK time zone)
Agenda
- 40 minutes presentation and then 20 minutes Q&A with the host Nathan Nagel
- Mechanisms linking glucose-lowering therapy and weight change
- Cardiometabolic and renal outcomes of SGLT2 inhibitors
-
-
How to prescribe safely: eGFR thresholds and sick-day rules
-
DPP-4 inhibitors and TZDs: managing expectations for weight impact
-
Ethnic variations in response and safety
-
Combining SGLT2 inhibitors with metformin for optimal results
-